<strike id="fvzf9"><input id="fvzf9"><form id="fvzf9"></form></input></strike>
    <strike id="fvzf9"><blockquote id="fvzf9"></blockquote></strike>
  1. 
    
  2. <label id="fvzf9"><optgroup id="fvzf9"></optgroup></label>

    <span id="fvzf9"><input id="fvzf9"></input></span>

  3. 掃碼關(guān)注公眾號           掃碼咨詢(xún)技術(shù)支持           掃碼咨詢(xún)技術(shù)服務(wù)
      
    客服熱線(xiàn):400-901-9800  客服QQ:4009019800  技術(shù)答疑  技術(shù)支持  質(zhì)量反饋  關(guān)于我們  聯(lián)系我們
    国产欧美精品一区二区_產(chǎn)品中心-北京博奧森生物技術(shù)有限公司
    首頁(yè) > 產(chǎn)品中心 > 一抗 > 產(chǎn)品信息
    DOCK1 Rabbit pAb (bs-7110R)  
    訂購熱線(xiàn):400-901-9800
    訂購郵箱:sales@bioss.com.cn
    訂購QQ:  400-901-9800
    技術(shù)支持:techsupport@bioss.com.cn
    50ul/1180.00元
    100ul/1980.00元
    200ul/2800.00元
    大包裝/詢(xún)價(jià)

    產(chǎn)品編號 bs-7110R
    英文名稱(chēng) DOCK1 Rabbit pAb
    中文名稱(chēng) 細胞質(zhì)分裂付出蛋白1抗體
    別    名 180 kDa protein downstream of CRK; Ced5; Dedicator of Cytokinesis 1; Dedicator of cytokinesis protein 1; DOCK 1; DOCK-1; DOCK 180; DOCK1; DOCK1_HUMAN; DOCK180.  
    研究領(lǐng)域 腫瘤  細胞生物  信號轉導  細胞凋亡  細胞自噬  G蛋白信號  
    抗體來(lái)源 Rabbit
    克隆類(lèi)型 Polyclonal
    交叉反應 Mouse (predicted: Human,Rat,Sheep,Cow,Chicken,Dog,Horse)
    產(chǎn)品應用 IHC-P=1:100-500,IHC-F=1:100-500,IF=1:100-500
    not yet tested in other applications.
    optimal dilutions/concentrations should be determined by the end user.
    理論分子量 215 kDa
    檢測分子量
    細胞定位 細胞漿 細胞膜 
    性    狀 Liquid
    濃    度 1mg/ml
    免 疫 原 KLH conjugated synthetic peptide derived from human DOCK1: 465-550/1865 
    亞    型
    純化方法 affinity purified by Protein A
    緩 沖 液 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
    保存條件 Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles.
    注意事項 This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
    PubMed PubMed
    產(chǎn)品介紹 Involved in cytoskeletal rearrangements required for phagocytosis of apoptotic cells and cell motility. Functions as a guanine nucleotide exchange factor (GEF), which activates Rac Rho small GTPases by exchanging bound GDP for free GTP. Its GEF activity may be enhanced by ELMO1.
    Tissue specificity: Highly expressed in placenta, lung, kidney, pancreas and ovary. Expressed at intermediate level in thymus, testes and colon.

    Function:
    Involved in cytoskeletal rearrangements required for phagocytosis of apoptotic cells and cell motility. Functions as a guanine nucleotide exchange factor (GEF), which activates Rac Rho small GTPases by exchanging bound GDP for free GTP. Its GEF activity may be enhanced by ELMO1.

    Subunit:
    Interacts with the SH3 domains of CRK and NCK2 via multiple sites. Interacts with nucleotide-free RAC1 via its DHR-2 domain. Interacts with ELMO1, ELMO2 and probably ELMO3 via its SH3 domain. Interacts with RAC1 and BAI1.

    Subcellular Location:
    Cytoplasm (Probable). Membrane (Probable). Note=Recruited to membranes via its interaction with phosphatidylinositol 3,4,5-trisphosphate (Probable).

    Tissue Specificity:
    Highly expressed in placenta, lung, kidney, pancreas and ovary. Expressed at intermediate level in thymus, testes and colon.

    Similarity:
    Belongs to the DOCK family.
    Contains 1 DHR-1 domain.
    Contains 1 DHR-2 domain.
    Contains 1 SH3 domain.

    SWISS:
    Q14185

    Gene ID:
    1793

    Database links:

    Entrez Gene: 1793 Human

    Entrez Gene: 330662 Mouse

    Entrez Gene: 309081 Rat

    Omim: 601403 Human

    SwissProt: Q14185 Human

    SwissProt: Q8BUR4 Mouse

    Unigene: 159195 Human

    Unigene: 645702 Human

    Unigene: 436572 Mouse



    ????????????????????????????????????乳腺癌轉移的新標記物DOCK1
    ????乳腺癌是一種常常發(fā)生轉移的癌癥。將近90%的乳腺癌患者都因為癌癥擴散而死,因此,理解這一危險過(guò)程的細胞和分子基礎機制是十分重要的。
    ????近日,加拿大蒙特利爾臨床研究所(Institut de recherches cliniques de Montreal, IRCM)的科學(xué)家在乳腺癌研究方面取得了一個(gè)重要的發(fā)現,他們確定了,一種名為DOCK1的蛋白質(zhì)可以作為潛在的靶標用于減少乳腺癌患者的癌轉移。相關(guān)研究結果刊登在了近期出版的《PNAS》上。
    ????研究人員在乳腺癌治療方面盡管已經(jīng)取得了重要的進(jìn)展,但是對于癌癥擴散的機制卻知之甚少??茖W(xué)家正在試圖確定能夠調節癌轉移過(guò)程的蛋白質(zhì),因為它們或許可以作為新的藥物靶標,并與現有的方法相結合促進(jìn)治療的效果。
    ????在這項研究中,2個(gè)主要的癌癥亞型——HER-2+型和Basal-like型,很容易轉移和復發(fā),并最終導致患者的低生存率。該調查以HER-2+(人類(lèi)表皮生長(cháng)因子受體2)型為研究對象, 這代表了大約25%的乳腺癌病例。 HER2陽(yáng)性腫瘤比其它類(lèi)型的腫瘤更傾向于快速的發(fā)展和擴散。
    ????研究人員解釋到,通過(guò)研究HER2+乳腺癌小鼠模型,確定了DOCK1蛋白質(zhì)是癌轉移的一個(gè)重要的調控因子。當去除了小鼠中的這一蛋白質(zhì)后,乳腺癌的肺轉移大大減少了。此外,研究發(fā)現DOCK1蛋白質(zhì)有助于腫瘤的生長(cháng)。
    ????為了證明DOCK1的表達與乳腺癌預后之間的關(guān)系,研究人員對包含患者基因信息的幾個(gè)數據庫進(jìn)行了分析。結果發(fā)現,在HER-2+型或Basal-like型乳腺癌中,高水平的DOCK1與較差的預后以及疾病的復發(fā)有關(guān)。
    產(chǎn)品圖片
    Paraformaldehyde-fixed, paraffin embedded (Mouse testis); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37°C for 30min; Antibody incubation with (DOCK1) Polyclonal Antibody, Unconjugated (bs-7110R) at 1:500 overnight at 4°C, followed by a conjugated secondary (sp-0023) for 20 minutes and DAB staining.
    版權所有 2004-2026 radiasunchina.com 北京博奧森生物技術(shù)有限公司
    通過(guò)國際質(zhì)量管理體系ISO 9001:2015 GB/T 19001-2016    證書(shū)編號: 00124Q34771R2M/1100
    通過(guò)國際醫療器械-質(zhì)量管理體系ISO 13485:2016 GB/T 42061-2022    證書(shū)編號: CQC24QY10047R0M/1100
    京ICP備05066980號-1         京公網(wǎng)安備110107000727號
    国产剧情演绎系列丝袜高跟|一级毛片av性爱黄色网站|欧美三级午夜理伦三级|国产av巨作情欲放纵|亚洲 欧美 中文 日韩aⅴ
    <strike id="fvzf9"><input id="fvzf9"><form id="fvzf9"></form></input></strike>
      <strike id="fvzf9"><blockquote id="fvzf9"></blockquote></strike>
    1. 
      
    2. <label id="fvzf9"><optgroup id="fvzf9"></optgroup></label>

      <span id="fvzf9"><input id="fvzf9"></input></span>